- Nanoveu (NVU) has successfully requested its securities be placed in back-to-back trading halts
- The two trading halts come as the company gets ready to announce a new capital raise
- Nanoveu ended the June quarter with more than $1 million in cash in the bank, after burning over $600,000 on operating costs
- The company also recently signed a distribution agreement to sell its antiviral protection products in the Thai and Malaysia markets
- Before today’s trading halts, shares in Nanoveu were trading for 8.3 cents per share on July 31
Nanoveu (NVU) has requested its securities be placed in back-to-back trading halts by the ASX as it gets ready to announce a capital raise.
The two trading halts were successfully implemented today and will last until August 7, or when the capital raise is announced in full.
In the meantime, the company recently announced it had ended the June quarter with more than $1 million worth of cash in the bank.
It also burnt $611,000 on operating costs during the three months to June 30, meaning it has enough cash in hand to last another 1.6 quarters if its operating costs remain at that level.
However, the company also said it expects to see sales of the company’s antiviral products start generating a margin in the future, helping to balance out its operating costs.
Along with the quarterly results, Navoneu also recently announced it had signed a new distribution agreement to sell its antiviral products in the Thai and Malaysia markets.
The agreement is with Sanyo Trading Company and has a combined consideration of US$2.2 million (around A$3.08 million). Under the agreement, Sanyo will sell Nanoveu’s antiviral film, antiviral mobile phone cases and door handle covers.
Before today’s trading halts were implemented, the company’s shares were trading for 8.3 cents per share on July 31.